Jeffrey Eisele insider trades
Open-market stock purchases and sales by Jeffrey Eisele, Chief Development Officer at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 23, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 15 sales, last Jan 29, 2025